secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2024-10-25T23:59:59+00:00
Accession:  0001641489-24-000069
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics receives termination notice for ppar-δ license from OnKure; effective Jan 2025
--------------------------------------------------------------------------------

- OnKure (formerly Reneo) notified vTv LLC intent to terminate the December 2017 License Agreement for vTv's ppar-δ agonist program IP.
- OnKure has decided to discontinue development of the licensed program.
- Termination becomes effective January 20, 2025.
- Agreement had been previously amended in December 2021.
- Financial impact of the termination was not disclosed by vTv.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148924000069/0001641489-24-000069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148924000069/vtvt-20241022.htm
  HTML page:      https://secwatch.observer/filing/0001641489-24-000069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer